Accounting for nearly 4 billion prescriptions, generic and biosimilar medicines saved the U.S. $338 billion in 2020 alone and almost $2.4 trillion over the last decade. As more biosimilars have come to market over the last few years, the U.S. has seen $8 billion in savings in 2020. Generics account for 90% of prescriptions dispensed in the U.S., but only 18.1% of the spending and 93% of all generic prescriptions are filled for less than $20.
Viatris Support for Greater Access in Healthier Markets